Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
株式のランク #27024
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
株価
$0.16240909
最終同期: 2025-03-04
時価総額
$35.68M
変化(1日)
0.27%
変化(1年)
0.00%
CN
取引 Dali Pharmaceuticalco.,Ltd (603963)

カテゴリー

Dali Pharmaceuticalco.,Ltd(603963)の利益
Sep 2024 時点の利益 TTM: $-3.27M
Dali Pharmaceuticalco.,Ltd の最新の財務報告によると、同社の現在の利益は $-3.27M です。2022 年には $-2.46M の利益を上げ、これは 2021 年の利益 $-6.54M と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Dali Pharmaceuticalco.,Ltd の利益の推移(2012 〜 2026)
各年末の利益
利益 変化
2026 (TTM) $-3.27M 33.35%
2023 $-2.45M -0.43%
2022 $-2.46M -62.34%
2021 $-6.54M -1,232.14%
2020 $578.00K -76.49%
2019 $2.46M 34.05%
2018 $1.83M -77.19%
2017 $8.04M -23.55%
2016 $10.52M -6.56%
2015 $11.26M -40.72%
2014 $18.99M 6.67%
2013 $17.81M -0.04%
2012 $17.81M 0.00%